Imaging the Effects of Bihemispheric Transcranial Stimulation and Motor Training After Stroke.

Sponsor
D'Or Institute for Research and Education (Other)
Overall Status
Unknown status
CT.gov ID
NCT04195412
Collaborator
Rio de Janeiro State Research Supporting Foundation (FAPERJ) (Other), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. (Other), Conselho Nacional de Desenvolvimento Científico e Tecnológico (Other)
24
1
2
23.1
1

Study Details

Study Description

Brief Summary

Functional and structural magnetic resonance imaging (MRI) will be used to investigate neural correlates of bihemispheric transcranial direct current stimulation (tDCS) associated with upper limb rehabilitation in chronic stroke patients. For this purpose, patients included will be submitted to 10 sessions with active or sham bihemispheric tDCS associated with intensive and individualized rehabilitation. Neuroimage will be employed before and after the intervention to investigate neural correlates of expected changes in motor function.

Condition or Disease Intervention/Treatment Phase
  • Device: tDCS + upper limb rehabilitation
  • Device: Sham tDCS + upper limb rehabilitation
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Neuroplasticity Following Bihemispheric Transcranial Direct Current Stimulation and Motor Training in Chronic Stroke Patients.
Actual Study Start Date :
Oct 29, 2019
Anticipated Primary Completion Date :
Oct 1, 2020
Anticipated Study Completion Date :
Oct 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: tDCS

Bihemispheric tDCS will be applied. The anode will be placed on the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. After stimulation, individual and intensive upper limb rehabilitation will be performed.

Device: tDCS + upper limb rehabilitation
Stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. Stimulation intensity will be 2 mA with current ramping up and down of 10 seconds each. The stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

Sham Comparator: Control

Bihemispheric sham tDCS will be applied. The anode will be placed on the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. After sham stimulation, individual and intensive upper limb rehabilitation will be performed.

Device: Sham tDCS + upper limb rehabilitation
Sham stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each sham stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. The anode will be placed to the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. Sham tDCS will be performed by ramping current flow for the first 10 seconds of stimulation, but switching the stimulator off automatically after 30 seconds. The sham stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

Outcome Measures

Primary Outcome Measures

  1. Treatment-related changes in functional magnetic resonance imaging [pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)]

    Brain functional changes from baseline to post-treatment

  2. Treatment-related changes in white matter [pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)]

    Brain structural (white matter) changes from baseline to post-treatment

Secondary Outcome Measures

  1. Changes in Fugl-Meyer assessment of paretic upper limb motor function [pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment); 30 days follow up (30 days after completing treatment) and 90 days follow up (90 days after completing treatment)]

    Fugl-Meyer Upper Extremity (FM-UE) Scale of Motor Impairment scores changes from baseline to post-treatment, 30 and 90 days later (follow up).

  2. Changes in Jebsen-Taylor Hand Function Test scores [pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 days]

    Fugl-Meyer Upper Extremity (FM-UE) Scale of Motor Impairment scores changes from baseline to post-treatment and in subsequent follow-up

  3. Changes in Stroke Impact Scale scores [pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 days]

    Stroke Impact Scale scores changes from baseline to post-treatment and in subsequent follow-up

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Chronic Stroke (> 12 months)

  • Upper limb sensorimotor sequelae due to stroke affecting only one cerebral hemisphere

  • The structural integrity of the corpus callosum sensorimotor

  • Showing ability to perform some movement with the paretic upper limb: at least minimal active mobility of the wrist and two fingers of the paretic hand.

  • Score ≥ 18 at Folstein Mini-Mental State Examination

Exclusion Criteria:
  • Score ≥ 4 at Ashworth Scale

  • MRI or tDCS contraindications (cardiac pacemakers; implanted medication pumps; cochlear, or eye implants; craniotomy, skin lesions at the site of stimulation; surgical clips in or near the brain; claustrophobia, history of seizures, permanent makeup or tattoos with metallic dyes…)

  • Prior neurological diseases

  • Hemodynamic instability

  • Pregnancy

  • Traumatic or orthopedic lesion limiting the range of upper limb motion

  • Severe comprehension deficits, apraxia or neglect that would interfere with performing the study tasks

  • Score > 59 at the Fugl-Meyer Assessment of Motor Recovery after Stroke

Contacts and Locations

Locations

Site City State Country Postal Code
1 D'Or Institute for Research and Education (IDOR) Rio De Janeiro Brazil 22281100

Sponsors and Collaborators

  • D'Or Institute for Research and Education
  • Rio de Janeiro State Research Supporting Foundation (FAPERJ)
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Investigators

  • Study Director: Fernanda F Tovar-Moll, PhD, D'Or Institute for Research and Education (IDOR)
  • Principal Investigator: Erika C Rodrigues, PhD, D'Or Institute for Research and Education (IDOR)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
D'Or Institute for Research and Education
ClinicalTrials.gov Identifier:
NCT04195412
Other Study ID Numbers:
  • PRJ1913
First Posted:
Dec 11, 2019
Last Update Posted:
Dec 11, 2019
Last Verified:
Dec 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by D'Or Institute for Research and Education
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 11, 2019